Skip to main content
. 2021 Summer;20(3):178–186. doi: 10.22037/ijpr.2020.114565.14915

Table 2.

Vital sign changes during the study period. SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; VAS: Visual Analogue Scale; POSAS: Patient and Observer Scar Assessment Scale

Vital sign Placebo
(N = 32)
Timolol
(N = 32)
P -value P -value ( repeated measure ANOVA)
SBP (mmHg) 0.021
Base line 112.1 ± 9.7 111.2 ± 10.5 0.748
Day 1 112.8 ± 8.5 108.5 ± 10.4 0.097
Day 2 113.2 ± 9.8 106.7 ± 8.3 0.007
Day 3 111.5 ± 8.8 107.1 ± 10.1 0.065
Day 4 112.9 ± 9.4 107.8 ± 9.0 0.024
DBP (mmHg) 0.070
Base line 70.4 ± 7.9 71.2 ± 9.0 0.883
Day 1 71.8 ± 7.8 68.5 ± 7.0 0.081
Day 2 72.1 ± 8.3 67.5 ± 7.1 0.021
Day 3 71.2 ± 7.5 67.5 ± 8.0 0.065
Day 4 72.1 ± 7.9 69.0 ± 6.8 0.089
Body Temperature (°C) 0.188
Base line 37.1 ± 0.4 37.0 ± 0.4 0..888
Day 1 36.9 ± 0.3 36.8 ± 0.3 0.328
Day 2 36.9 ± 0.4 36.6 ± 0.3 0.002
Day 3 36.8 ± 0.3 36.8 ± 0.4 0.389
Day 4 36.7 ± 0.3 36.7 ± 0.3 0.388
Respiratory Rate (n/min) 0.007
Base line 16.5 ± 2.9 17.7 ± 2.5 0.066
Day 1 17.9 ± 1.5 18.3 ± 0.8 0.091
Day 2 17.6 ± 1.2 18.4 ± 0.9 0.008
Day 3 17.3 ± 1.6 18.3 ± 0.6 0.006
Day 4 17.6 ± 1.2 18.2 ± 0.8 0.051
Heart Rate (n/min) 0.716
Base line 79.3 ± 7.1 81.8 ± 4.5 0.050
Day 1 80 ± 4.0 78.4 ± 3.0 0.115
Day 2 79.9 ± 3.8 78.6 ± 2.2 0.089
Day 3 79.3 ± 3.5 79 ± 2.0 0.884
Day 4 79 ± 3.6 78.4 ± 2.0 0.514